These final results, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assist the notion of concentrating on ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders.Importantly, these receptors have